Key Points Two issues holding down Pfizer might not be as significant as they seem. Prudential's long-term growth prospects remain solid. Verizon's underlying business is strong, with growth likely to accelerate in the coming years. 10 stocks we like better than Pfizer › The stock market is richly valued. Warren Buffett knows it. Federal Reserve chair Jerome Powell knows it. You and I know it, too. Does that mean there aren't any good stocks to buy right now? Nope. Some are even bargains. Here a ...